Felicita Baratelli Selected Research

Felicita Baratelli Research Topics

Disease

9	Neoplasms (Cancer) 11/2013 - 03/2003
8	Lung Neoplasms (Lung Cancer) 01/2013 - 03/2003
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2013 - 12/2003
2	Carcinogenesis 11/2013 - 10/2004
1	Ulcerative Colitis 04/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2014
1	Infections 11/2003
1	Lung Diseases (Lung Disease) 11/2003
1	Emphysema 11/2003
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2003

Drug/Important Bio-Agent (IBA)

4	Dinoprostone (PGE2)FDA Link 08/2005 - 12/2003
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 06/2005 - 03/2003
2	Chemokine CCL21IBA 01/2013 - 05/2011
2	Interleukin-10 (Interleukin 10)IBA 05/2011 - 12/2003
2	ProstaglandinsIBA 06/2005 - 12/2003
2	Celecoxib (Celebrex)FDA Link 10/2004 - 12/2003
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2004 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 11/2003 - 03/2003
1	Hematoxylin (Haematoxylon)IBA 04/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2013
1	Interleukin-27 (Interleukin 27)IBA 11/2013
1	LigandsIBA 01/2013
1	CytokinesIBA 05/2011
1	NanocapsulesIBA 05/2011
1	HLA-DR Antigens (HLA-DR)IBA 06/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2010
1	Prostaglandins EIBA 06/2010
1	SurvivinIBA 08/2005
1	Transcription Factors (Transcription Factor)IBA 06/2005
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2005
1	LeukotrienesIBA 10/2004
1	EicosanoidsIBA 10/2004
1	Calcimycin (A23187)IBA 12/2003
1	Biomarkers (Surrogate Marker)IBA 12/2003
1	AntigensIBA 11/2003
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2003
1	Peptide Hydrolases (Proteases)FDA Link 11/2003
1	ImmunosorbentsIBA 11/2003
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2003
1	EnzymesIBA 11/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2003
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2003
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2003
1	Histocompatibility Antigens Class IIIBA 03/2003
1	Histocompatibility Antigens Class IIBA 03/2003
1	Peptides (Polypeptides)IBA 03/2003

Therapy/Procedure

2	Therapeutics 01/2013 - 11/2003
2	Chemoprevention 10/2004 - 12/2003
1	Drug Therapy (Chemotherapy) 01/2013
1	Radiotherapy 01/2013
1	Injections 07/2008